D
CRISPR Therapeutics AG CRSP
$41.86 $3.298.53% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income -385.66M -366.25M -239.59M -265.80M -217.14M
Total Depreciation and Amortization 19.16M 19.26M 19.32M 19.50M 19.62M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 59.39M 47.95M 54.81M 54.97M 58.10M
Change in Net Operating Assets 628.00K 156.27M -23.35M 69.57M -20.00M
Cash from Operations -306.47M -142.77M -188.82M -121.76M -159.42M
Capital Expenditure -1.39M -1.90M -2.39M -4.28M -7.13M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -201.05M -278.58M -465.38M -180.53M 166.15M
Cash from Investing -202.44M -280.48M -467.76M -184.81M 159.02M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 37.10M 332.45M 354.51M 346.43M 363.19M
Repurchase of Common Stock -466.00K -466.00K -466.00K -466.00K --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 36.64M 331.98M 354.05M 345.96M 363.19M
Foreign Exchange rate Adjustments 31.00K -21.00K 127.00K 4.00K 30.00K
Miscellaneous Cash Flow Adjustments -- -- -1.00K -1.00K -1.00K
Net Change in Cash -472.24M -91.29M -302.41M 39.40M 362.82M